Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
5-24-2012

Occulomotor Function and Locomotion in Parkinson's Disease
Corey Lohnes
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Lohnes, Corey, "Occulomotor Function and Locomotion in Parkinson's Disease" (2012). All Theses and
Dissertations (ETDs). 713.
https://openscholarship.wustl.edu/etd/713

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS

Interdisciplinary Program in Movement Science

Dissertation Examination Committee:
Gammon Earhart, Chair
Richard Abrams
Beth Crowner
Catherine Lang
Michael Mueller
Joel Perlmutter

Occulomotor Function and Locomotion in Parkinson’s Disease
by
Corey Alfred Lohnes

A dissertation presented to the
Graduate School of Arts and Sciences
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy

May 2012
Saint Louis, Missouri

Abstract of the Dissertation
Many persons with Parkinson’s disease (PD) experience difficulty turning that
can lead to freezing of gait, falls, and an increased risk of fall-related injuries. We
hypothesized, based on previous literature, that turning difficulty and freezing during
turning may be related to deficits in the ability to switch from one motor pattern to
another (Chapter 2). We further hypothesized that deficits in oculomotor control,
particularly in the case of voluntary saccades, also contribute to the pathogenesis of
turning difficulty since turning is normally initiated with an eye movement (Chapter 3).
Finally, we hypothesized that current treatment approaches including pharmacological
and surgical interventions would improve turning performance and oculomotor
performance in individuals with PD (Chapter 4).
To determine whether individuals with PD have trouble switching motor patterns
with the eyes and whether they experience similar deficits in the lower limb, we tested
healthy controls and persons with PD during an orientation switch task. The PD group
delayed orientation switching that was attributable to bradykinesia, and there was a
correlation in the amount of impairment across body parts. These results suggest that
while individuals with PD may take longer to switch from one motor pattern to another,
bradykinesia may be the driving factor as opposed to an internal deficit in the ability to
switch motor programs. Regardless of mechanism, delays in switching motor patterns
may play a role in freezing and turning difficulty.
To determine if oculomotor function is abnormal in PD during turning and
whether this contributes to turning difficulty, participants with PD and healthy controls
performed in-place 90º and 180° turns. Turn performance was worse in PD (i.e., longer
ii

time to turn, more steps) and those with PD made more saccades during the turns.
Further, the saccade initiating the turn was smaller, slower, and exhibited altered timing
relative to the first step of the turn in those with PD compared with controls. Finally,
saccade performance was correlated with turn performance in those with PD. Our results
suggest that the oculomotor strategy used by those with PD is altered and less efficient as
compared with controls, and that oculomotor dysfunction may be a contributing factor in
turning difficulty.
To determine if therapeutic interventions could improve oculomotor function and
related turning performance, we tested individuals with PD and deep brain stimulation
(DBS) of the subthalamic nucleus. Gait parameters and turn duration improved with both
levodopa therapy and DBS, but only DBS was successful in improving concurrent
oculomotor function. The amplitude and velocity of the first saccade improved with
DBS, while the latency of the first saccade decreased relative to the onset of head rotation
and the first step.
Taken together, these studies corroborate previous knowledge that voluntary
saccades are dysfunctional in PD. Further, these studies relate oculomotor impairment to
a functional task and give insight into the role of therapeutic interventions for improving
turning difficulty in PD. These results also provide support for using visual cueing to
improve turning performance and therefore, future research should examine the efficacy
of such cues on turning performance.
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Chapter 1: Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative condition that affects
nearly 1.5 million people in the U.S. PD is primarily a disease of the basal ganglia with
pathophysiology characterized by selective degeneration of dopaminergic neurons in the
substantia nigra pars compacta and accumulation of alpha-synuclein “Lewy bodies”
throughout the brain. While the disease also presents with non-motor symptoms, the four
cardinal motor symptoms of tremor, rigidity, postural instability, and bradykinesia
combine in a motor disorder that can severely limit mobility, activities of daily living,
and quality of life. Among the myriad motor disturbances associated with PD,
impairments in gait are the most common cause of disability. Forward walking is
impaired through a reduction in gait velocity and stride length, while gait transitions such
as initiation, navigating obstacles, and turning elicit further dysfunction. Turning
difficulty (TD) is extremely problematic as turning is very common during locomotion
and activities of daily living but is a primary trigger for freezing of gait (FOG), often
leading to falls 1. This is significant as falls that occur during turning are eight times more
likely to result in a hip fracture than falls during straight line walking 2, contributing to a
3.2 fold greater risk of hip fractures in PD compared with age-matched individuals
without PD 3. It is clear that addressing TD in individuals with PD would offer lower risk
for injury and improved function, yet the underlying causes of TD are not well
understood, limiting our ability to offer therapeutic strategies to those affected.
Eye and Limb Control in PD
According to Mink’s center-surround hypothesis of basal ganglia function,4
decreased availability of dopamine and overactivity of the sub-thalamic nucleus (STN) in
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PD lead to excessive inhibition of desired and undesired movements. Bradykinesia,
hypokinesia, and in severe cases, akinesia result and can be observed during limb
movements, functional tasks, and even during eye movements. For example, hypokinesia
can include undershooting targets during reaching tasks,5 micrographia,6 and reduced
stride length during gait. Bradykinesia is evident during a multitude of movements
including gait, large amplitude ballistic movements, tasks requiring accuracy, and object
tracking tasks.7 The oculomotor system is similarly affected, albeit differentially
depending on the nature of the task. Reflexive, or visually guided saccades, are largely
unaffected in the early stages of PD,8 but show reduced gain and increased latency during
later disease stages.9,10 Deficits in smooth pursuit can be observed in milder patients
during tasks where the subject is required to follow a slowly oscillating target.11 Finally,
voluntary saccades, defined as eye movements that are internally generated as opposed to
eye movements in response to an external visual stimulus, appear to be the most affected
as deficits can be measured in early stages of PD and are observed before deficits in
reflexive saccades.12 In summary, voluntary saccades in people with PD are slower and
smaller than those of control subjects.8,12-15
Motor Pattern Switching in PD
Beyond the aforementioned impairments, individuals with PD also experience
difficulty in selecting and executing new motor patterns16,17 along with difficulty
planning and performing sequential18 and simultaneous motor acts.19 It is hypothesized
that FOG may be a manifestation of such difficulties in switching between motor
programs, and we suggest that TD and related freezing episodes are examples of this.
Multiple studies have reported motor switching difficulty in the upper extremity. Plotnik
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et al.20 found that patients with PD have impaired ability to process motor responses to
successive stimuli, while Inzelberg et al.21 confirmed this with a similar upper extremity
task and also showed that motor switching deficits were not correlated with mental
switching deficits, hypothesizing separate mechanisms. During upper extremity point-topoint and reversal movement tasks, muscle activation, kinetics, and kinematics were
affected in subjects with PD.22 In a study by Leis et al.23, when persons with PD were
required to change a planned action they showed substantially pronounced decrements in
movement performance, such as slowness and greater variability, indicating that
modifying a planned action affects subsequent motor execution. Difficulty changing
motor patterns has also been noted beyond the upper extremity. In studying the sit-tostand task in PD and controls, Mak and Hui-Chan 24 propose that slowness in PD patients
could be attributed to difficulties in switching direction from flexion to extension at the
bottom of task. Finally, in a study of oculomotor switching, the ability to respond to
unanticipated changes in target amplitude was well maintained in PD, probably due to the
benefits of external cueing associated with this type of tasks, but the ability to respond to
unanticipated changes in target direction was decreased, characterized by greater
variability in latency and in accuracy. This study suggests that changes in saccade
direction may rely on the basal ganglia. Overall, there is a large body of literature
supporting deficits in the ability to modify and switch between motor plans, but none of
these studies have been performed in the lower extremity specifically or with the eyes.
Turning in Healthy Controls and PD
Visual information plays a key role in locomotion and therefore impairments in
visual processing increase locomotor dysfunction. It has been shown that older adults
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with visual impairments (i.e., loss in visual acuity) fall more frequently than those
without visual impairments,25-27 and clear differences in gaze behavior have been
demonstrated between older adult fallers and non-fallers during obstacle navigation
tasks.28 Visual information is important for turning as well. During turns, studies on
healthy controls show that a top-down rotation sequence is used whereby the eyes are the
first to rotate. This initial saccade, combined with a subsequent head turn, provides a
shift of gaze to a position aligned with the direction of travel. This initial change in gaze
is then followed by rotation of the head, trunk, and feet. 29-32 This sequence is thought to
provide the central nervous system with an external, or global, reference frame that is
used to control body movement in space such that one goes where one is looking.31,33
While turning has been well described in healthy controls, few studies have
focused on turning in PD. In a case report, Morris et al.34 noted that their subject used an
increased number of steps and a narrower base of support compared to a control subject.
He also displayed reduced movement of the pelvis and upper trunk during turning. Stack
et al.35 noted that individuals with a history of freezing or falls used a greater number of
steps to turn and appeared unstable during turns. Recent work has demonstrated that
subjects with PD tend to turn en bloc, i.e. rotating the head and trunk simultaneously
rather than in sequence, and require greater time to turn.36-38 The work of Crenna et al.36
is particularly interesting because it reveals that turning deficits are present even in
individuals with mild PD who as of yet have no alteration or impairment in their straight
walking. This suggests that turning difficulty may affect individuals with PD even from
a very early stage of the disease when other symptoms are not yet apparent. Although
oculomotor control is found to be dysfunctional in PD during isolated saccade tasks, no
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research has been done to date to characterize how this translates to turning and impacts
turning kinematics.
Therapeutic interventions
Multiple studies have examined the effect of interventions on oculomotor function
in persons with PD. The efficacy of levodopa, the most commonly prescribed medication
for PD, in improving saccade function is still a matter of debate. Saccade amplitude
appears to be largely unaffected by levodopa,39,40 while saccade latency decreases during
voluntary saccades 41,42 and increases during reflexive saccades.42,43 On the other hand,
deep brain stimulation (DBS) has proven very beneficial for improving saccade function
in PD. Improvements in gain and latency during both voluntary and reflexive saccades
have been measured when STN DBS is turned on vs. off.44-47 The effect of therapeutic
interventions on turning has not been as widely studied.
Scope of Thesis
This research was designed to understand the contribution of oculomotor
impairments to locomotor dysfunction in PD. In summary, chapter 2 examines the
correlation between oculomotor and lower limb impairments in PD, chapter 3 describes
the impact of oculomotor dysfunction on turning in both PD and controls, and chapter 4
studies the effect of interventions on turning performance and related oculomotor control
in PD.
Specific Aim 1: (Chapter 2)
To determine whether individuals with PD have difficulty switching movement direction
during movements of the eyes and lower limbs.
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Hypothesis 1a: Individuals with PD will display deficits in the ability to change
movement orientation with the eyes and lower limbs as compared with healthy controls.
Hypothesis 1b: Deficits in the ability to change movement orientation of the eyes will be
related to ability to change movement orientation of the lower limb, indicative of a
similar level of impairment across different body parts.
Specific Aim 2: (Chapter 3)
To determine whether eye movements during turning are impaired in individuals with
PD who have difficulty turning during walking, and to determine whether characteristics
of the saccade that initiates a turn are predictive of ensuing turn performance.
Hypothesis 2a: Individuals with PD will demonstrate slower, smaller saccades at turn
initiation and will make more saccades during the turn compared to controls.
Hypothesis 2b: The amplitude, velocity, and latency of the saccade initiating a turn will
be predictive of the time required to execute the turn. We expect turns that are initiated
with slower, smaller, and later saccades will take longer to complete.
Specific Aim 3: (Chapter 4)
To determine the independent and combined effects of medication and DBS of the STN
on saccadic eye movements during turning and turning performance in persons with PD.
Hypothesis 3a: Both anti-Parkinson medication and STN DBS will independently
improve the amplitude and timing of the saccade initiating turns and turning
performance, but STN DBS will result in greater improvements than medication.
Hypothesis 3b: Improvements in saccade performance during turning with DBS will be
additive with the effects of medication.

6
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Chapter 2: Movement orientation switching with the eyes and lower limb in
Parkinson’s Disease

This chapter is in press:
Lohne CA, Earhart GM. Movement orientation switching with the eyes and lower limb in
Parkinson’s Disease. Parkinsonism and Related Disorders. (2012).
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Abstract
Difficulty switching between motor programs is a proposed cause of motor blocks in
Parkinson disease (PD). Switching from one movement to another has been studied in the
upper extremity and during postural control tasks, but not yet in the eyes and lower limb
in PD. The purpose of this study was to compare movement orientation switching ability
between people with PD and age-matched controls (CON) and to determine if switching
ability is correlated between the eyes and lower limb. Twenty-six persons with PD and 19
age-matched controls participated. Movement orientation switching was studied in a
seated position with the head fixed in a chinrest. In response to a randomly generated
tone, participants switched from a continuous back-and-forth movement in either the
horizontal or vertical orientation to the opposite orientation as quickly as possible. Lower
limb movements were performed with the great toe pointing back and forth between
targets positioned on a 45º angled floor platform. Eye movements were back and forth
between the same targets. Eye and lower limb switch time was reduced in PD (p<0.01),
but after normalizing switch time to movement velocity, no differences existed between
PD and CON. Eye and lower limb switch times were correlated in PD (r=0.513, p<0.01)
but not in CON. In PD, switch time and movement velocity of the lower limb, but not
the eyes, correlated with bradykinesia and postural instability/gait. Our results suggest
that individuals with PD experience movement switching deficits with both the eyes and
lower limb, perhaps driven by overall bradykinesia.
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1. Introduction
Many persons with Parkinson disease (PD) experience bradykinesia and akinesia
that often lead to functional decline including decreased mobility, freezing of gait, and a
higher risk of fall-related injuries. According to the center-surround hypothesis, basal
ganglia dysfunction in PD may lead to excessive inhibition of desired and undesired
movements,1 leading to difficulty with selection and execution of the desired movement.
This difficulty has been cited as a mechanism underlying problems with changing from
one motor program to another,2-4 with extreme difficulties in switching motor programs
perhaps contributing to the freezing phenomenon.5 As freezing of gait is quite often
triggered by turning, we hypothesize that difficulties in switching between motor patterns
in order to change direction of movement may underlie the turning difficulties noted in
many individuals with PD. Such impairments related to switching movement direction
have been reported for upper extremity movements and postural control tasks.4,6,7 Pfann
et al.7 even noted pauses, perhaps analogous to the freezing of gait sometimes triggered
by turning, at the points of direction change during upper extremity movements. Specific
impairments related to changing directions have also been hypothesized to contribute to
difficulties with sit to stand movements in individuals with PD.8
When considering direction changes, particularly during locomotion, one should
not overlook the role of eye movements. Saccadic eye movements play an important role
in locomotion as they provide a shift in gaze toward the direction of travel and initiate the
top-down rotation sequence characteristic of a normal turning pattern.9-11 Saccadic eye
movements, however, are impaired in PD, as evidenced by a large body of evidence.
Early work in persons with PD showed prolonged fixation times, bradykinesia, and
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akinesia during rapid alternating gaze shifts between two fixed targets.12 Several more
recent studies have demonstrated that people with PD make slower and smaller voluntary
saccadesthan control subjects.13-15 The basal ganglia (BG) circuitry may be particularly
important for changing saccade direction,16 and saccade dysfunction is associated with
turning difficulty in persons with PD.17 During both 90 and 180 degree turns, the saccade
initiating the turn is hypometric and displays altered timing relative to turn onset when
compared with healthy controls.
To our knowledge, deficits in ability to change movement directions of the eyes
and lower limbs have yet to be examined in the same individuals with PD. Therefore, the
purpose of this investigation was to confirm whether individuals with PD have difficulty
switching between two movement orientations with the eyes and lower limbs, and to
determine if the ability to switch movement orientation with the eyes is correlated with
switching ability in the lower limb. We hypothesized that deficits in the ability to change
movement orientation with the eyes and lower limbs would be noted in individuals with
PD, and that the deficits in the eyes and limbs would correlate with one another,
indicating a similar amount of decline in orientation switch ability across different body
parts. Confirmation of our hypotheses would support an overlap between oculomotor
and lower limb control in the dysfunctional BG and provide important insights into the
nature of eye and limb control in PD.
2. Methods
2.1 Participants
Twenty-six individuals with idiopathic PD (17 men, 9 women; age = 70.2 ± 10.5;
PD duration 8.4 ± 6.0 years, Hoehn & Yahr stage = 2.3 ± 0.4; MDS-UPDRS III score =
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41.0 ± 11.1) and 19 age-and gender-matched controls (11 men, 8 women; age = 67.7 ±
10.6 years) participated. Sample size was based on a-priori power analysis using switch
time pilot data; 20 subjects per group would provide 87% power to detect a 0.7 effect size
using a two-tailed, 2-way ANOVA (p = 0.05). Individuals with PD were recruited from
Washington University School of Medicine’s (WUSM) Movement Disorders Center.
Controls were recruited from the Volunteers for Health Database, posted flyers, and other
WUSM volunteer databases. All subjects met the following inclusion criteria: aged 30
years or older, normal central (except for PD in the PD group) and peripheral
neurological function, able to stand independently for at least 30 minutes and walk
independently without an assistive device, no history of vestibular disease and no
evidence or history of dementia. Exclusionary criteria included: serious medical
condition other than PD, use of neuroleptic or other dopamine-blocking drug, use of drug
that might affect balance such as benzodiazepines, evidence of abnormality on brain
imaging (previously done for clinical evaluations-not part of this research), history or
evidence of other neurological deficit, and history or evidence of orthopedic, muscular, or
psychological problem that may affect task performance. Additionally, participants with
PD were included based on a diagnosis of “definite PD” by a board certified neurologist,
as previously described by Racette et al.18 based upon established criteria19,20 and were
excluded if they had received surgical management of PD (e.g. deep brain stimulation).
All subjects gave informed consent to perform experimental procedures approved by the
Human Research Protection Office at WUSM.
2.2 Experimental procedures
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All procedures were performed in the Locomotor Control Laboratory at WUSM.
Participants with PD were tested OFF medication, i.e. after a 12-hour withdrawal of all
anti-Parkinson medications. Before testing procedures commenced, the Movement
Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Motor
Subscale III was administered according to Goetz et al.21 by a trained rater. The MDSUPDRS-III is a measure of severity of PD motor symptoms, as well as physical
disability, and includes measures of rigidity, gait, tremor, hand/arm and leg movements
(bradykinesia), speech, and facial expressions. The modified Hoehn and Yahr scale was
used to evaluate disease severity in PD.22 FOG was assessed using the Freezing of Gait
Questionnaire (FOG-Q), 23 with total FOG-Q score representing overall FOG severity,
and freezers identified as those who reported freezing of gait at least once per week on
item three or the questionnaire.
During the protocol, each participant performed eye and lower limb movement
tasks while in a seated position. Lower extremity tasks were performed with the
dominant limb. For all movement tasks, four white targets were placed on a black angled
platform (45º relative to the floor) located on the floor in front of the subject. Targets
were positioned 20 centimeters apart such that eye movements between targets would be
approximately 25 degrees (Figure 1). Each subject was seated with his head resting in a
chinrest to minimize head movement and angled downward such that the platform was
positioned in the center of the visual field. The platform was centered in front of the
subject at a distance that allowed for comfortable movement of the lower limb. To
investigate the ability to switch movement orientation (switch task), participants began
the task by moving either their eyes or lower limb (pointing with the big toe) back and
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forth as quickly as possible between two targets (either horizontally or vertically). Upon
hearing an auditory tone, participants were instructed to switch movement orientation as
quickly as possible and continue moving back and forth in the new orientation. Multiple
orientation switches, including both horizontal-to-vertical (HV) and vertical-to-horizontal
(VH) switches, were performed at random times during each trial with 4-6 orientation
switches per 30 second trial. Auditory cues were triggered by the first author by pressing
a button which sounded the signal. Throughout each trial, the interval between switches
was random as that the tester did not time the interval between switch cues and made an
effort to vary the time interval from switch to switch.
To control for differences in reaction time between PD and CON, simple reaction
times (RT) of the lower limb and eyes were tested. Each participant began with eyes
fixated or great toe positioned on a target centered between the 4 peripheral targets used
for the switch task. Upon hearing a tone, the participant reacted as quickly as possible to
move either left, right, up, or down, as instructed prior to each trial. To control for
differences in movement velocity between PD and CON, participants also performed
three 10 second trials of back and forth movements of the eyes or lower limb, moving as
quickly as possible between the horizontal targets without switching orientations so that
average movement velocity could be determined. For all tasks, participants were given
the opportunity to practice the task and data collection commenced when the participant
was comfortable performing the task.
2.3 Data collection and processing
Lower limb movements were captured using an eight camera, passive marker, 3dimensional, high-resolution motion capture system sampling at 100 Hz in Cortex
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software (Motion Analysis Corporation, Santa Rosa, CA). One retro-reflective marker
was positioned at the base of the great toe. The motion capture system was calibrated
both statically (calibration frame) and dynamically (wand) prior to each data collection
session. Ocuolmotor data were captured using a head-mounted infrared binocular eye
tracking system (Applied Sciences Laboratory, Bedford, MA) and electrooculography
(EOG). Oculomotor data were captured synchronously at 1000Hz on the same PC
workstation with kinematic data in Cortex software. The infrared eye tracking system
was calibrated for each participant using a two step process. First, a nine-point relative
points methods was used to calibrate the eye tracking system. Then, participants
performed saccades of known amplitudes in four directions (up, down, left, right) to
allow conversion of analog data (millivolts) into angle data (degrees).
Lower limb marker data and analog data were filtered using 4th order low-pass
Butterworth filters. Marker data were filtered in Cortex with a cut-off frequency of 6 Hz
while analog data were filtered in MotionMonitor (Innsport, Chicago, IL) with a cut-off
frequency of 20 Hz. A global coordinate system was defined in MotionMonitor with the
positive X-axis pointing anteriorly, positive Y-axis pointing to the left and positive Z-axis
pointing upward vertically. Toe marker kinematic data and filtered analog data were
exported for further processing in custom written MATLAB software (The Mathworks,
Inc, Natick, MA).
For the orientation switch task, switch time was defined as the time interval
between the auditory tone and the beginning of first full amplitude movement in the new
orientation. As each trial contained multiple VH and HV switches, VH and HV switches
were measured separately and an average switch time was determined for each switch
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orientation. For the RT tasks, RT was defined as the time interval between auditory tone
and movement onset (lower limb movement exceeding 5 mm from origin and eye
movements exceeding 0.5 degrees from origin). For the movement velocity task,
movement velocity was calculated as the number of back and forth cycles completed
during a measured time period multiplied by the average movement amplitude across all
of the cycles within the trail. Finally, to control for the effect of movement velocity,
switch times were normalized to movement velocity by multiplying the two measures.
Individual trials were excluded from analysis if artifacts in oculomotor data due to blinks,
prolonged closure of eyelids, or other factors precluded measurement. Remaining trials
within a condition were averaged to obtain a single data point for each subject for each
task.
2.4 Data Analysis
Independent Student’s t-tests were used to compare between-group differences in
movement velocity, movement amplitude, and normalized switch time for both the eyes
and lower limb, and a Bonferroni correction was used to control for multiple
comparisons, bringing the level of significance for the t-tests to p<0.0045. A mixed
model was used to test the effect of group, segment (eye vs. lower limb), and the groupsegment interaction on switch time and RT. Segment was treated as a repeated measure.
Pearson’s correlation coefficients were used to test the correlation between eye and lower
limb switch times as well as the correlation between switch time and movement velocity.
Spearman’s rank order correlations were used to examine correlations between
movement parameters (amplitude, velocity, switch time) and FOG and the MDS-UPDRS
III. The criterion for statistical significance was set at p<0.05 for all analyses.
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3. Results
Eye movements in the vertical plane could not be captured for a number of
participants (13 PD and 2 CON). Therefore, only movement tasks in the horizontal plane
and VH orientation switches are reported. Age did not differ between PD and CON (t =
.799, p = 0.429), nor did RT (F = 1.703, p = 0.199), although RT was slower in the lower
limb (F = 28.343, p < 0.001). Movement velocity was not statistically different between
PD and CON for the eyes (t = 1.505, p = 0.140), but was decreased in PD for the lower
limb (t = 3.710, p = 0.001). There was a significant group effect for switch time (F =
20.99, p <0.001), but neither the main effect of segment nor the group-segment
interaction were significant (F=2.386, p = 0.130; F = 0.143, p = 0.707, respectively).
Although switch time was significantly different between groups, normalized switch time
did not differ significantly between groups for the eyes (t = 1.683, p = 0.100) or lower
limb (t = 1.138, p = 0.261). During the movement velocity task, average lower limb and
eye movement amplitudes closely approximated the expected values based on target
placement (20 cm/ 25 degrees apart), and there were no group differences for the eyes (t
= 0.453, p = 0.653) or lower limb (t = 1.949, p = 0.058). Eye and lower limb
performance data are displayed in Table 1.
Across all participants, switch times of the eyes and lower limb were
significantly correlated (r = 0.425, p = 0.004), but normalized switch times of the eyes
and lower limb were not significantly correlated (r = 0.257, p = 0.088). Within PD, eye
and lower limb switch time did not correlate significantly (r = 0.286, p = 0.186) but
normalized switch times correlated significantly (r = 0.513, p = 0.007). Within CON,
neither correlation was significant (switch time, r = 0.089, p = 0.719; normalized switch
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time, r = -0.058, p = 0.812) (Figure 2). In PD, FOG was correlated with lower limb
velocity (ρ = -.483, p = 0.013), amplitude (ρ = -0.552, p = 0.007), and switch time (ρ =
0.503, p = 0.009). Total MDS-UPDRS-III scores correlated with lower limb switch time
(ρ = 0.502, p=0.009), velocity (ρ = 0.551, p = 0.004), and amplitude (ρ = -0.606, p =
0.001). MDS-UPDRS-III scores were also divided into sub-scores reflecting tremor
(items 3.15 – 3.18), rigidity (item 3.3), bradykinesia (items 3.4 – 3.8), and postural
stability and gait (PIGD, items 3.9 – 3.13). PIGD correlated with lower limb switch time
(ρ = 0.558, 0.003), velocity (ρ = -0.617, p = 0.001) and amplitude (ρ = -0.430, p =
0.032). Bradykinesia correlated with lower limb switch time (ρ = 0.412, p = 0.036) and
velocity (ρ = -0.493, p = 0.010). Eye switch time and velocity did not correlate
significantly with any of the MDS UPDRS III sub-scores. These correlations are shown
in Figure 3. Finally, switch time and movement velocity were significantly correlated in
the eyes (r = -0.587, p < 0.001) and in the lower limb (r = -0.749, p< 0.001) across all
participants.
Comparing freezers and non-freezers, groups did not differ in terms of movement
velocity (eye, t = 1.045, p = 0.306; lower limb, t = 1.134, p = 0.268) or amplitude (eye, t
= 0.007, p = 0.995; lower limb, t = 0.852, p = 0.403). The main effect of eye vs. lower
limb was significant for RT (F = 21.248, p < 0.001) with RT being slower in the lower
limb. Both the main effect of group (F = 0.039, p = 0.845) and the interaction (F = 1.343,
p = 0.258) were not significant for RT. Switch time main effect of group (F = 1.081, p =
0.309), eye vs. lower limb (F = 1.936, p = 0.177), and the interaction (F = 3.247, p =
0.084) were all non-significant.
4. Discussion
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This study sought to determine whether the ability to switch movement
orientation with the eyes and lower limbs is impaired in PD and whether orientation
switch ability is similar between the eyes and lower limbs. In summary, persons with PD
took longer to switch movement orientation with both the eyes and lower limb, and
displayed a reduction in lower limb movement velocity. When normalizing switch time
to movement velocity, the significant group effects of switch time were negated. Across
both PD and CON, eye switch time correlated significantly with lower limb switch time,
and in persons with PD, FOG, UPDRS, PIGD, and bradykinesia correlated significantly
with lower limb function, while oculomotor function did not correlate with these
measures. There were no differences between PD freezers and non-freezers in terms of
switch time, movement velocity, or movement amplitude
Our hypothesis was supported in that persons with PD required 37% and 41%
more time to switch orientation with their eyes and lower limb, respectively, compared to
controls. However, since eye and lower limb movement velocities were slower in PD
compared with CON, we normalized orientation switch times to movement velocity. In
doing so, we noted that normalized switch times were similar between PD and controls,
indicating that if PD were to move at the same velocity as the controls, their orientation
switch ability may be comparable for both the eyes and lower limbs. As hypothesized,
normalized lower limb switch times explained 26% of the variance in normalized eye
switch times in PD, but this relationship did not hold true for controls.
Our finding of prolonged switch times in PD corroborates previous research. In
the upper extremity, Almeida et al.24 observed delays in switching between two
coordination patterns in the upper extremity, while Plotnik et al.6 showed that people with
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PD respond poorly to movement modifications. To our knowledge, this is the first study
to report such findings in the lower extremity and eyes. Further, previous studies in the
upper extremity did not account for movement velocity. Herein, we demonstrate that
accounting for movement velocity negates the group differences in orientation switch
ability. Thus, observed deficits in the ability to switch movement direction/orientation in
our study and others, indicative of a deficit in motor program switching, may be simply a
function of global bradykinesia. Regardless, it is clear that the overall time required to
change from one movement paradigm to another in response to an external stimulus is
greater in PD. This difficulty may contribute to FOG which is often triggered by a
change in movement, such as switching from straight walking to turning. The modest
delay in switching between simple motor programs observed in the present study may
manifest in a much longer delay or freeze when the motor programs are more
complicated (i.e. gait). A delay in switching could also be a contributing factor in falls,
as a delay in selecting and executing the proper motor response to an unanticipated
perturbation or change in body position may not allow enough to time to catch oneself
before a point of no return. Finally, our study supports previous work showing deficits in
oculomotor function in PD. Visual information plays an important role in gait and people
with PD show deficits in saccade performance that relate to impaired turning
performance17 and may contribute to FOG and falls.
While the basal ganglia are often described as having distinct loops for
oculomotor and motor control, evidence suggests that the subthalamic nucleus (STN)
may play key roles in the control of both eye and limb movements, indicating overlap of
the oculomotor and motor loops. Some neurons within the STN respond to voluntary
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saccades as well as limb movements.25 The timing and characteristics of saccade-related
potentials in STN suggest that these cells are responsible for broad non-specific
inhibitory output to inhibit unwanted motor programs, whether for the eyes or the
limbs.26 Disruption of this inhibitory output from the STN could account for impairments
in voluntary saccades27 and limb movements. Abnormal STN output may also contribute
to difficulty turning that can trigger FOG, as evidenced by the fact that STN deep brain
stimulation can alleviate off-period freezing.28-30 The apparent overlap between
oculomotor and motor control in the basal ganglia provides a potential anatomical
substrate where a pathophysiological disruption could contribute to impaired eye and
limb movements and also to turning difficulties. Our data suggest that eye and lower
limb switching are mildly correlated, supporting the potential for overlap between
oculomotor and lower limb control by the basal ganglia and a global bradykinesia that
appears to influence eye and limb movements similarly. In line with a center surround
hypothesis,1 the common bradykinesia of the eyes and lower limbs may be due to overactivity of the subthalamic nucleus leading to excessive inhibitory output from the basal
ganglia. In support of a global bradykinetic cause for delays in switching movement
orientation in the tasks we studied, our global bradykinesia score obtained from the
MDS-UPDRS-III correlated with lower limb orientation switch times, as did the PIGD
score.
While we conclude that differences in switch time between PD and CON are
driven by bradykinesia, it is important to consider alternative hypotheses. Since the
switch task involved reacting to an auditory stimulus, differences in switch times could
be attributed to differences in RT between PD and CON. However, RT did not differ
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between groups for either the lower limb or eyes, thus RT is unlikely to have contributed
to group differences in switch time. An alternative hypothesis to our bradykinesia
explanation is that persons with PD suffer from a deficit in the ability to select and
execute a new or different motor program, and that this deficit is at least partially
independent of bradykinesia. If this were the case, we would expect group differences in
switch time to remain even after controlling for movement velocity (normalized switch
times), indicated that bradykinesia does not fully explain the effect of group on switch
time. However, this was not the case as normalized switch times were very similar
between PD and CON for both the eyes and lower limb. Further support for our
bradykinesia hypothesis is that movement velocity and switch time were highly
correlated in both the eyes and lower limb across all subjects, and that there were no
differences between freezers and non-freezers in the ability to switch movement
orientation.
4.1 Limitations
During the movement velocity and orientation switch tasks, participants were
provided with visual cues in the form of targets. A large body of existing literature
supports the use of various types of visual cueing strategies for improving movement in
PD. Therefore, it is possible that movement amplitude and switching ability were
enhanced in PD by the presence of targets. Additionally, the lower limb and eye
movements required for the tasks herein were of relatively small amplitude (20cm for the
lower limb and 25 degrees for the eyes). Since the performance of those with PD
compared well with controls in terms of movement amplitude, it is possible that the intertarget distance chosen was too small to elicit hypokinetic movement in PD.

25

4.2 Conclusions and future directions
Switching between movement contexts is impaired in PD and affects not only
upper and lower limb movements, but eye movements as well, and the severity of
dysfunction is similar between eyes and lower limb. It appears that global bradykinesia
may be a factor affecting switching ability in PD. Future work should explore movement
switching ability of the lower limbs during more complex and functionally relevant tasks,
such as during locomotion.
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Figure 1:
Experimental set-up. (A) Participants were seated in a chair with their head positioned in
a chinrest to minimize head movement and with their head tilted downward. A binocular
head-mounted eye tracking device was secured to their head in this position. A black
platform was positioned on the floor in front of the subjects. The platform was angled 45
degrees to the floor with round white targets positioned on the face of the platform. (B)
Configuration of targets for the orientation switch task. (C) Configuration of targets for
the reaction time task.
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Figure 2:
Correlation between eye and lower limb switch times for CON (top) and PD (bottom).
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Figure 3: Correlations of lower limb switch time (left column) and movement velocity
(right column) with MDS-UPDRS III, Bradykinesia, PIGD, and FOG in subject with PD
only.
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Table 1. Eye and Lower Limb Performance Data.

Measure

PD

(n)

Controls

(n)

Eye RT (sec)

0.293 ± 0.061

26

0.286 ± 0.034

18

Foot RT (sec)

0.360 ± 0.064

26

0.336 ± 0.062

19

Eye Velocity (degrees/sec)

48.05 ± 15.9

26

54.84 ± 13.5

19

Foot Velocity (cm/sec)

34.40 ± 12.6

25

47.89 ± 11.2

19

Eye Amplitude (degrees)

24.8 ± 4.2

26

25.1 ± 0.9

19

Foot Amplitude (cm)

18.5 ± 0.01

25

19.3 ± 0.01

19

Eye Switch Time (sec)

1.00 ± 0.294

26

†

0.731 ± 0.134

19

Foot Switch Time (sec)

1.11 ± 0.366

26

†

0.789 ± 0.126

19

Normalized Eye Switch Timea

45.25 ± 12.42

26

39.56 ± 9.26

19

Normalized Foot Switch Timeb

34.46 ± 7.34

26

36.96 ± 7.17

19

Values are means ± standard deviations.
a,b

Arbitrary units

* Significant group effect, p < 0.05
† Significant group effect, p < 0.01
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Chapter 3: Saccadic eye movements are related to turning performance in
Parkinson’s disease
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Abstract
Background. Persons with Parkinson’s disease (PD) experience difficulty turning, leading
to freezing of gait and falls. We hypothesized that saccade dysfunction may relate to
turning impairments, as turns are normally initiated with a saccade. Objective. Determine
whether saccades are impaired during turns in PD and if characteristics of the turninitiating saccade are predictive of ensuing turn performance. Methods. 23 persons with
PD off medication and 19 controls performed 90 and 180 degree in-place turns to the
right and left. Body segment rotations were measured using 3-D motion capture and
oculomotor data were captured using a head-mounted eye tracking system and
electrooculography. Total number of saccades and the amplitude, velocity, and timing of
the first saccade were determined. Results. Turn performance (turn duration, number of
steps to turn) was impaired in PD (p<0.05). PD performed more saccades, and the
velocity and timing of the first saccade was impaired for both turn amplitudes (p<0.05).
Amplitude of the first saccade was decreased in PD during 180 degree turns. Turn
duration correlated with oculomotor function. Characteristics of the first saccade
explained 48% and 58% of the variance in turn duration for 90 and 180 degree turns,
respectively. Conclusions. Turning performance is impaired in PD and may be influenced
by saccade dysfunction. An association between saccade function and turning
performance may be indicative of the key role of saccades in initiating proper turning
kinematics. Future work should focus on improving saccade performance during
functional tasks and testing the effects of therapeutic interventions on related outcomes.
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative disease that is
associated with a reduction in mobility, with problems that include difficulty turning.
Turning difficulties can lead to freezing of gait (FOG), falls, fear of falling, and social
withdrawal.1-3 Falls that occur during turning are eight times more likely to result in hip
fracture than falls during straight line walking.4 Furthermore, individuals with PD have a
3.2 fold greater risk of hip fracture than age-matched individuals without PD.5 In
addition to the large personal cost of turning difficulties, hip fractures represent a
substantial financial burden to society, with the cost of hip fracture care in individuals
with PD totaling approximately $192 million per year in the United States.5,6
Studies focusing on turning have noted that individuals with PD require more
steps and take longer to complete a turn than healthy controls.7-11 Those with PD who
report turning difficulty also have a higher incidence of freezing of gait and falls.10,12
Furthermore, the timing of segmental rotations during turn initiation is altered in PD.
This has been termed “en bloc” turning and is characterized by the near simultaneous
rotation of the head, trunk, and pelvis and reduced relative rotations between adjacent
segments.9,13-15 Other measures of poor turn quality have been observed in those with PD
including a wider turn arc16, narrowed step width11,16,17, and higher variation in step
duration compared with controls.16
It is evident that visual information plays an important role in the control of
locomotion and turning. Clear differences in gaze behavior and stepping performance
have been demonstrated between older adult fallers and non-fallers.18 In addition,
training of eye movements has been shown to improve locomotor performance in
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individuals with cerebellar damage.19 Several studies in healthy individuals have shown
that the eyes participate in a top-down rotation sequence such that the eyes are the first to
turn, followed by the head, trunk, and then the feet.20-23 The initial saccade during a turn,
in combination with subsequent head movements, provides a shift of gaze to a position
aligned with the direction of travel. Gaze shifts precede shifts in center of mass (COM)
trajectory during turning and unexpected perturbations of gaze cause delays in COM
movement to steer the body along the desired trajectory.24
While eye movements have been measured in healthy adults during turning tasks,
it is unclear how eye movements relate to turning performance in individuals with PD.
During head-fixed tasks, saccadic eye movements have been shown to be abnormal in
those with PD, including prolonged fixation times, bradykinesia, and akinesia during
rapid alternating gaze shifts between two fixed targets.25 Several more recent studies
have demonstrated deficits in control of voluntary saccades in people with PD,
consistently noting that saccades are slower and smaller than those of control subjects.2630

Briand et al29 reviewed a series of 15 studies of voluntary saccades and noted that all

but one of these studies reported voluntary saccade performance inferior to that of control
subjects in individuals with PD. Therefore, we hypothesize that saccadic eye movements
performed during turns are also likely abnormal and may contribute to impaired turn
performance. A disruption of the normal top-down rotation sequence by poor saccade
timing or decreased saccade amplitude may contribute to the altered turning kinematics
reported in those with PD. Hence, the purposes of this study were to determine whether
saccadic eye movements during turning are impaired in individuals with PD and to
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determine if characteristics of the saccade that initiates a turn are predictive of ensuing
turn performance.
METHODS
Participants
Twenty-three individuals with idiopathic PD and 19 age- and gender-matched
controls participated in this investigation. Individuals with PD were recruited from a
database of patients from Washington University School of Medicine’s (WUSM)
Movement Disorders Center. Control participants were recruited from the Volunteers for
Health Database, posted flyers, and other healthy volunteer databases associated with
WUSM. All subjects met the following inclusion criteria: aged 30 years or older, normal
central (except for PD in the PD group) and peripheral neurological function, able to
stand independently for at least 30 minutes and walk independently without an assistive
device, no history of vestibular disease and no evidence or history of dementia.
Exclusionary criteria included: any serious medical condition other than PD, use of
neuroleptic or other dopamine-blocking drug, use of drug that might affect balance such
as benzodiazepines, evidence of abnormality on brain imaging (previously done for
clinical evaluations-not part of this research), history or evidence of other neurological
deficit, such as previous stroke or muscle disease, and history or evidence of orthopedic,
muscular, or psychological problem that may affect task performance during the study.
Additionally, participants with PD were included based on a diagnosis of “definite PD”
by a board certified neurologist, as previously described by Racette et al. (1999) based
upon established criteria (Calne et al. 1992, Hughes et al. 1992) and were excluded if
they had received surgical management of PD (e.g. pallidotomy or deep brain
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stimulation). All subjects gave informed consent to perform experimental procedures
approved by the Human Research Protection Office at WUSM.
Experimental Procedures
All study procedures were performed in the Locomotor Control Laboratory at
WUSM. Participants with PD were tested OFF medication, i.e. after a 12-hour
withdrawal of all anti-Parkinson medications. Before testing procedures commenced, the
Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)
Motor Subscale III was administered according to Goetz et al31 by a trained rater. The
MDS-UPDRS-III is a measure of severity of PD motor symptoms, as well as physical
disability, and includes measures of rigidity, gait, tremor, hand/arm and leg movements
(bradykinesia), speech, and facial expressions. The modified Hoehn and Yahr scale also
was used to evaluate disease severity in PD.32
During the experimental protocol, participants completed in-place turns of 90
degrees and 180 degrees amplitude. Instructions were given to perform the turns in a
comfortable and normal fashion. No specific auditory or visual cues were provided to
cue turn onset or completion other than directing subjects to “turn 90 degrees to face the
wall beside you” or “turn 180 degrees to face the wall behind you”, accordingly.
Participants were instructed to begin the movement anytime after receiving the turn
direction instruction of left or right for the given trial. Turns were completed to both the
right and left in randomized order and all 90° turns were completed prior to beginning the
block of 180° turns. Participants completed a minimum of 5 turns in each direction.
Data quality was visually monitored in real time and additional turns were completed as
needed to insure an adequate number of quality trials for analysis.
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Full body kinematic data were captured using an eight camera, passive marker, 3dimensional, high –resolution motion capture system (Motion Analysis Corporation,
Santa Rosa, CA) sampling at 100 Hz in Cortex software (Motion Analysis Corporation,
Santa Rosa, CA). Thirty-eight retro-reflective markers were positioned on the head (top
of head, back of head, left ear, right ear), trunk (left and right acromion, right scapula,
sternal notch, xyphoid process, 7th cervical vertebra, 12th thoracic vertebra), pelvis (left
and right anterior superior iliac spine, left and right posterior superior iliac spine,
sacrum), both legs (greater trochanter, anterior thigh, medial and lateral femoral condyle,
tibial tuberosity, front of shank, medial and lateral malleolus) and both feet (calcaneus,
navicular, distal 2nd metatarsal). Ocuolmotor data were captured using a head-mounted
infrared binocular eye tracking system (Applied Sciences Laboratory, Bedford, Ma) and
electrooculography (EOG). Oculomotor data were captured synchronously at 1000Hz on
the same PC workstation with kinematic data in Cortex software.
Data Processing
Individual kinematic marker data and analog data were filtered using 4th order
low-pass Butterworth filters. Marker data were filtered in Cortex with a cut-off
frequency of 6 Hz while analog data were filtered in MotionMonitor (Innsport, Chicago,
IL) with a cut-off frequency of 20 Hz. Global and segment coordinate systems were
defined in MotionMonitor with the positive X-axis pointing anteriorly, positive Y-axis
pointing to the left, and positive Z-axis pointing upward vertically. Rotations of the head,
trunk, pelvis, and feet about global Z were extracted using a Z-X-Y Euler sequence.
Subsequently, kinematic angle data and filtered analog data were exported for further
processing in custom written MATLAB software (The Mathworks, Inc, Natick, MA).
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Time of onset for segment rotations (relative to the global coordinate system) was
determined by identifying the first frame at which the rotation reached five degrees above
baseline. Similar criteria were used to identify turn offset, defined as the frame at which
the rotation came within five degrees of maximal, final position. Eye tracker and EOG
data were used to identify and measure saccades occurring just prior to and during turn
performance. Saccades were identified visually and later confirmed to be true saccades if
the maximum velocity of the eye movement exceeded 30 degrees/sec.33,34 Onsets and
offsets of the first saccade associated with each turn were identified visually. Using these
time points, saccade amplitude, peak velocity, and timing of the first saccade relative to
head and foot rotations were calculated. Example trials are shown for an individual with
PD and a control in Figure 4.
Individual trials were excluded from analysis if eye position or body segment
rotations about the global Z-axis were not static for at least 1000ms prior to turn onset.
Trials were also excluded if artifacts in oculomotor data due to blinks, prolonged closure
of eyelids, or other factors precluded measurement of the initial saccade. Remaining
trials within a condition (90 or 180 degrees) were averaged to obtain a single data point
for each subject. Left and right turns were combined for analysis as turn performance did
not differ between leftward and rightward turns.
Data Analysis
Independent Student’s t-tests were used to compare between-group differences in
turn performance and oculomotor performance during both 90 and 180 degree turns. Our
primary variables of interest were the amplitude and velocity of the saccade initiating the
turn, the total number of saccades performed during the turn, and the timing of the first
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saccade relative to onsets of head and foot rotations. The latencies between the first
saccade and head/foot rotations were normalized to the duration of the first gait cycle and
are reported as a percentage of the first gait cycle time. We also employed a linear
regression model with turn duration as the dependent variable and number of saccades,
initial saccade velocity and normalized timing of the saccade relative to turn onset as the
independent variables to identify the amount of variance in turn performance accounted
for by characteristics the saccade initiating the turn. Saccade amplitude and the
normalized timing of the saccade relative to head rotation onset were not included in the
model as they were highly correlated with the included variables. The criterion for
statistical significance was set at p<0.05.
RESULTS
Demographic data are displayed in Table 1. Data from three participants included
in the 90 degree turn analysis could not be included in the analysis for the 180 degree
turn due to poor oculomotor data quality. Conversely, one participant was included in the
180 turn analysis but omitted from the 90 degree analysis for similar reasons. Regardless
of turn type, age did not differ between PD and controls.
Turn performance was impaired in PD compared with controls, with both 90 and
180 degree turns requiring more steps (p<0.05) and a greater time to complete (p<0.01).
PD also performed a greater number of saccades during their turns, and the peak velocity
of the initial saccade was slower in PD for both 90 and 180 degree turns (p<0.01). The
amplitude of the initial saccade was less in PD than in controls for 90 degree turns only
(p<0.01). The normalized latency between start of the first saccade and start of the first
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step (Norm E-F Index) was different between groups, with PD performing the first
saccade earlier relative to the onset of foot rotation (<0.05, Table 2).
The number of saccades, initial saccade amplitude, initial saccade velocity, and
Norm E-F Index were all significantly correlated with turn duration (Figure 5). Turn
duration, which was highly correlated with the number of steps required to turn, was used
as the dependent variable representing turn performance in our regression analysis. The
linear regression model, which included both PD and controls, explained a significant
amount of the variance in turn duration for both 90 degree (R2 = .481, F(3,27)=11.4, p <
.001) and 180 degree (R2 = .578, F(3,25) = 16.0, p < .001) turns. Table 3 reports the
unstandardized (B) and standardized (β) regression coefficients for these models.
Comparing freezers and non-freezers, turn duration and number of steps were
greater in subjects who reported freezing of gait at least once per week on item 3 of the
FOG questionnaire (p<0.05). Mean values for initial saccade velocity and Norm E-F
Index differed between freezers and non-freezers, but these comparisons did not reach
statistical significance. Despite the lack of statistical significance, the effect sizes,
measured using Cohen’s d, were moderate to large. Effect size for saccade velocity
between freezers and non-freezers equaled 0.91 for 90 degree turns and 0.52 for 180
degree turns. Norm E-F Index effect sizes were 0.8 for 90 degrees turns and 0.86 for 180
degree turns. Number of saccades and initial saccade amplitude were similar between
freezers and non-freezers. Data comparing freezers and non-freezers is presented in Table
4.
DISCUSSION
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This study sought to determine whether saccadic eye movements performed
during turning are impaired in individuals with PD and to determine if characteristics of
the saccade that initiates a turn are predictive of ensuing turn performance. In
confirmation of our hypotheses, saccadic eye movements were impaired during turning in
persons with PD and these impairments were related to turning dysfunction. Individuals
with PD used a greater number of saccades to complete both 90 and 180 degree turns, the
initial saccade was both smaller (180 degrees only) and slower than that of controls, and
the timing of the initial saccade relative to the turn onset was altered in those with PD.
Furthermore, turn performance was impaired in persons with PD and approximately 50%
of the variance in turn performance was explained by saccade performance across all
participants. Differences in saccade performance between the 90 and 180 degree turns
were largely predictable. The 180 degree turns required approximately twice as many
saccades as the 90 degree turns and the amplitude of the initial saccade was similar
between turn magnitudes for both groups. This suggests that the size of the turninitiating saccade is constant for turns of 90 degrees and larger, and that simply more
saccades are performed for large turns. Similarly, the delay between the first saccade and
turn onset did not differ between the two turn magnitudes.
Previous research widely demonstrates that voluntary saccade performance is
impaired in persons with PD.25-30 These studies, however, have focused only on simple
head-fixed tasks or on saccades performed in conjunction with head movements from a
seated position. Studying the oculomotor system using simple saccade paradigms has
allowed researchers to better understand basal ganglia disorders using a simple,
predictable, and well understood motor system. However, little information has been
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gathered from such studies regarding the implications of oculomotor impairments on
functional activities in those with PD. To the best of our knowledge, this is the first study
to report saccade performance during a more complex, functional task in people with PD.
Our novel findings support previous work that voluntary saccades are impaired in PD and
lend support to the idea that the eyes play a key role in turning. The turning sequence has
been characterized in healthy controls and consists of a top-down rotation sequence led
by the eyes and followed by rotations of the head, trunk, pelvis, and feet.20-23 In
individuals with PD this sequence is impaired, characterized by smaller intersegmental
rotations and altered timing of segment rotations.9,13,14 The present study reveals that the
turning sequence in PD is also characterized by a longer than normal delay between the
first saccade and the initiation of the gait cycle, as well as a smaller and slower saccade at
the beginning of the turn. Functionally, this manifests in reduced turn performance. As
evidenced by the strong correlations between saccade performance (the number of
saccades, saccade velocity, and saccade timing) and turn performance (number of steps
and turn duration), the degree of oculomotor impairment may impact turn quality.
Our finding of a greater delay between the initial saccade and the rest of the
turning sequence in the PD group is contrary to our hypothesis. Expanding the PD enbloc turning phenomenon to include eye movements, one would expect the eyes to rotate
more in sync with the head, trunk and feet, as opposed to our observation of a longer
latency between the eyes and feet. Our PD group actually performed the first saccade
much earlier in the rotation sequence than did the controls, and the longer latencies were
unexpectedly associated with a longer turn duration and more steps. This finding may be
explained by a generalized bradykinesia that affects both the motor and oculomotor
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systems. While the basal ganglia are often described as having distinct loops for
oculomotor and motor control, recent evidence suggests an overlap in control of both eye
and limb movements by the subthalamic nucleus (STN), as neurons in the STN respond
to both voluntary saccades and limb movements.35

Therefore, the greater delay between

eye movement and turn onset seen in PD may be the result of a dysfunctional common
motor pathway responsible for an overall bradykinetic turn sequence. Based on this,
deep brain stimulation (DBS) may prove beneficial for improving turn performance in
PD by enhancing both eye and limb movements. Levodopa therapy, the most common
treatment for those with PD, provides minimal improvement in both turn performance
and voluntary saccade performance.36,37 However, DBS of the STN in persons with PD
has shown considerable efficacy in improving motor performance, including gait and
performance of voluntary and reflexive saccades.38-40. However, no studies to date have
examined the effect of DBS on turn performance, nor the effect of DBS on saccade
function during functional tasks. Therefore, future work should target the effects of STNDBS on turn performance and associated oculomotor performance.
Studies extending beyond PD corroborate a relationship between oculomotor
dysfunction and gait impairments; a relationship that appears to be related to risk of
falling in a range of populations. In a study comparing elderly individuals who were at
high risk for falling with those at low risk for falling, a longer delay between horizontal
saccade initiation and initiation of footlift was observed in the high-risk group during a
precise walking task.41 Differences in gaze behavior have also been shown between adult
fallers and non-fallers.18 In patients with progressive supranuclear palsy (PSP), those
with more severe gaze palsy displayed an altered stepping pattern when navigating
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obstacles, placing them at higher risk for trips and falls.42 In our study, subjects who
reported FOG at least once per week displayed turn performance deficits and altered
saccade timing and velocity, although the comparison of oculomotor measures failed to
reach statistical significance, possible due to the small group sizes. Disease severity
(MDS-UPDRS III) and duration were not different between freezers and non-freezers,
illustrating that FOG is a specific pathology not present in all PD patients regardless of
disease stage or severity.2 While we did not obtain fall history records in this study, FOG
has been shown to be a risk factor for falling, and thus the freezers in our study likely
represent a sample of patients at higher risk for falls and fall-related injuries. Taken
together, our study and those of other pathological populations suggest a relationship
between fall risk and gait/oculomotor function. Therefore, rehabilitation strategies aimed
at decreasing the risk of falls during ambulation, and in particular during turning, are
important.
Cueing has received considerable attention over the past decade as a means of
improving temporal and spatial parameters of gait in persons with PD. Rhythmic
auditory, visual, and attentional cues have been shown to improve stride length and gait
velocity during straight walking.43-46 However, the ability of cues to improve turning
performance is less well understood. When rhythmic auditory cues were used during a
U-turn task, only step time variability was improved among a number of turn
performance parameters.16 In contrast, another study found that rhythmic auditory and
somatosensory cues improved turn time in a functional task (carrying a tray).47 Clearly,
more work is necessary to determine the effect of cues on turning, and based on the
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importance of oculomotor function during turning, using cues to promote a more
appropriate oculomotor strategy during turns should be of interest.
Limitations
One limitation of this study is that saccades were measured using two separate
measurement systems. The infrared binocular eye tracking system served as our primary
measurement tool, with EOG serving a secondary role. Due to the technical nature of
measuring pupil and corneal reflections using the infrared system, quality infrared data
could not be obtained from all participants. In such cases, EOG data were used for
analysis. To verify agreement between these two measurement systems, infrared and
EOG data were compared using data from participants for whom we had both data sets.
When comparing the timing, amplitude, and velocity of the initial saccade, values
obtained from the two systems compared exceptionally well. Therefore, the authors felt
confident in pooling data obtained from either measurement system.

Another

limitation of this study is that measurement occurred in a laboratory setting and thus
participants were aware that their performance was being monitored. Hence, it is
possible that participants’ oculomotor and turning performance may have differed from
their usual performance in a more natural setting. The authors think, however, that such
effects are minimal and would have been experienced similarly by both groups, thus not
detracting for our findings.
Conclusions and Future Directions
It is evident that turning difficulty is a primary trigger for freezing and falls in PD,
and our study indicates that impaired voluntary saccades may contribute significantly to
this problem. Rehabilitative strategies might consider focusing on cueing persons with
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PD to initiate turns with a more appropriate top-down rotation sequence, initiated by a
large amplitude saccade prior to commencing the gait cycle. Accordingly, future
research should be directed towards studying the effects of cueing and practice on the
ability to improve saccade performance during turns, and whether such improvements
offer meaningful improvements in turn performance and related fall risk. Additionally,
future work may assess the effects of therapeutic interventions (e.g. deep brain
stimulation) on such variables.
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Figure 4. Representative data from individual turn trials showing eye, head, and
foot rotations in the horizontal plane.
Panel A: Representative 90 degree turn performed by an individual with PD. The subject
performed 8 saccades of varying amplitudes during the turn, and required 3 steps to
complete the turn. Panel B: Representative 90 degree turn performed by a healthy
control. The subject performed only 5 saccades during the turn and required only 2 steps
and less time to complete the turn than the individual with PD. Panel C: Representative
180 degree turn performed by an individual with PD. The subject performed 15 saccades
of varying amplitudes during the turn, and required 5 steps to complete the turn. Panel D:
Representative 180 degree turn performed by a healthy control. The subject performed 8
saccades of more consistent amplitude than those performed by the individual with PD,
and required only 4 steps and less time to complete the turn than the individual with PD.
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Figure 5. Correlations between turn duration and various parameters of saccade
performance.
Correlations include all subjects from both the PD and control groups, with Pearson
correlation coefficients shown in top right of each panel. The left column shows
correlations of saccade number (A), amplitude of the first saccade (B), velocity of the
first saccade (C), and normalized timing of the first saccade relative to the first step (D)
for 90 degree turns. The right column (E-H) shows the same correlations for 180 degree
turns.
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Table 1. Subject Demographics

Age (years)
Male/Female
PD Characteristics
Disease Duration (years)
Hoehn & Yahr Stage
(# in each stage)

PD (90° turns)

PD (180° turns)

Controls

68.7 ±10.2
14/8

68.6 ±10.8
13/7

68.8 ± 11.4
11/8

7.4 ± 5.8
2.3 ± 0.4
Stage 1 = 1
Stage 2= 9
Stage 2.5 = 10
Stage 3 = 2

6.8 ± 5.6
2.3 ± 0.4
Stage 1 = 1
Stage 2= 7
Stage 2.5 = 10
Stage 3 = 2

Freezing of Gait Score
5.7 ± 4.8
No. Freezers (FOG 3 ≥ 2)
8
MDS-UPDRS III Score
40.1 ± 11.9
Values are means ± standard deviations.

5.8 ± 5.0
8
38.7 ± 11.5
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Table 2. Turn Performance and Oculomotor Performance During 90 and 180 Degree Turns
_________________________________________________________________________________________________________
90° Turns
180° Turns
Measure
PD
Controls
PD
Controls
# of Steps
4.3 ± 2.6
*
2.7 ± 0.8
7.7 ± 5.1
*
4.5 ± 0.9
Turn Duration (seconds)
2.1 ± 0.8
†
1.4 ± 0.5
3.6 ± 1.5
†
2.4 ± 0.7
# of Saccades
First Saccade Amplitude (degrees)
First Saccade Velocity (deg/sec)
Norm E-H Index (% of 1st gait cycle)
Norm E-F Index (% of 1st gait cycle)

4.5 ± 1.7
†
20.6 ± 8.1
219.0 ± 65.6 †
19.4 ± 19.3
45.4 ± 33.9 *

3.1 ± 1.4
25.7 ± 8.4
273.1 ± 41.1
11.5 ± 6.1
25.4 ± 9.7

Values are means ± standard deviations.
* Significantly different between groups, p < 0.05
† Significantly different between groups, p < 0.01
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8.9 ± 3.2
17.4 ± 4.6
206.7 ± 61.2
26.8 ± 25.0
52.3 ± 38.1

†
†
†
*
*

6.0 ± 1.5
24.7 ± 6.7
255.3 ± 39.5
13.4 ± 7.2
28.1 ± 11.5

Table 3. Results of Linear Regression Analysis

90° Turns

180 ° Turns

# Saccades
Saccade Velocity
Norm E-F Index

# Saccades
Saccade Velocity
Norm E-F Index
2
90° Turns, R = .481
180° Turns, R2 = .578

B
18.24
-.232
94.59

SE (B)
6.40
.18
36.93

β
.392
-.180
.329

p
.007
.211
.015

18.72
-.283
147.01

5.79
.28
53.01

.407
-.248
.337

.003
.048
.009
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Table 4. Comparison of Freezers and Non-Freezers
____________________________________________________________________________________________________________
90° Turns
180° Turns
Freezers (n=8)
Non-Freezers (n=14)
Freezers (n=8)
Non-Freezers (n=12)
Disease Duration
8.6 ± 7.0
6.7 ± 5.2
8.3 ± 6.7
5.8 ± 4.8
MDS-UPDRS III Score
40.1 ± 13.1
40.1 ± 11.7
39.9 ± 12.9
37.8 ± 11.0
# Saccades
4.5 ± 2.0
Saccade Amplitude (degrees)
20.6 ± 8.5
Saccade Velocity (deg/sec)
183.8 ± 59.8
Norm E-F Index
61.1 ± 49.0
Total Steps
6.4 ± 3.6
Turn Duration (seconds)
2.8 ± 8.1
Values are means ± standard deviations.
*Significantly different between groups, p < 0.05
†Significantly different between groups, p < 0.05

*
†

4.6 ± 1.6
20.7 ± 8.2
239.2 ± 61.7
36.4 ± 18.2
3.1 ± 0.5
1.6 ± 0.4
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9.1 ± 2.6
18.2 ± 3.4
187.7 ± 61.5
70.8 ± 48.1
11.1 ± 6.7
4.7 ±1.7

*
*

8.8 ± 3.7
16.9 ± 5.4
219.4 ± 60.2
40.0 ± 24.8
5.4 ± 1.1
2.8 ± .77
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Abstract
Background: Persons with Parkinson’s disease (PD) experience turning difficulty, often
leading to freezing of gait and falls. Visual information plays a significant role in
locomotion and turning, and while the effects of medication and deep brain stimulation
(DBS) on oculomotor function have been well documented, the effects of each on
oculomotor function during turning and on turning itself have yet to be fully elucidated.
Objective: To determine the separate and combined effects of levodopa and STN DBS on
turning performance and related oculomotor performance in PD. Methods: Eleven
subjects with PD and DBS of the subthalamic nucleus performed a seated voluntary
saccade task and standing 180° turns. Oculomotor data were captured using an infrared
eye tracking system while segment rotations were measured using 3-D motion capture.
Results: During the seated saccade task, neither medication nor DBS improved saccade
amplitude or latency, while DBS alone improved gait velocity and stride length during
forward walking. During turning, both medication and DBS improved turn performance
(turn duration) and reduced the number of saccades performed during the turns. DBS
increased the amplitude and velocity of the saccade initiating the turn while medication
had no effect. DBS decreased the intersegmental latencies (eye-head, eye-foot, and headtrunk) but this effect was lost for eye-head and eye-foot after controlling for the duration
of the first gait cycle. Conclusions: DBS significantly improves turn performance and
related oculomotor performance while medication has a minimal effect. These findings
add to the growing list of therapeutic benefits offered by DBS.
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INTRODUCTION
Turning during gait is common and required during normal ambulation and
activities of daily living. Individuals with Parkinson’s disease (PD), however, experience
difficulty turning, leading to freezing of gait (FOG), falls, and fear of falling.1-3 Falls
during turns are eight times more likely to result in hip fracture than falls during straight
line walking, and individuals with PD have a 3.2 fold greater risk of hip fracture than
age-matched individuals without PD.4 Hip fractures represent a substantial financial
burden to society, with the cost of hip fracture care in individuals with PD totaling
approximately $192 million per year in the United States.5
Recent studies have attempted to elucidate the cause of turning difficulty in PD in
order to develop strategies to overcome the issue. Such studies have noted that persons
with PD require more steps and take longer to complete a turn than healthy controls.6-9
Additionally, individuals with PD show altered timing of segmental rotations during turn
initiation, such that their turning strategy is more “en bloc” than healthy controls,8,10-12
although this finding may not be observed in early PD stages.13 It is also clear that visual
information plays an integral role in this turning sequence. In healthy controls, the eyes
participate in the top-down rotation sequence such that they eyes precede the sequential
rotations of the head, trunk, and feet.14 In subjects with PD, however, the amplitude of
the initial saccade is smaller than in healthy controls, a greater number of smaller
saccades are performed during the turn, and the timing of the initial saccade relative to
the first step is altered.9,13 These oculomotor deficits are consistent with a large body of
literature supporting voluntary saccade dysfunction in PD. Prolonged fixation times,
bradykinesia, and akinesia during rapid alternating gaze shifts have been observed in PD,
and voluntary saccades are widely described as being smaller and slower in PD.15 In
67

gaze re-orienting tasks where the eyes rotate in concert with the head to fixate on a lateral
target, eye-head coordination is found to be abnormal such that both saccades16 and head
rotations 16,17 are delayed, hypometric, and slow.
Few studies have been done to determine the effects of interventions on turning in
PD. While levodopa therapy was effective in improving MDS-UPDRS III scores and
gait velocity in one study, congruent with previous research,18 the effect on turn duration,
steps to turn, and the timing of body segment rotations was minimal.19 Similarly, the
effects of anti-Parkinson medications on saccade function are mixed. While the
amplitude of voluntary saccades appears to be resistant to levodopa therapy,20,21 levodopa
may have a beneficial effect on voluntary saccade latencies22,23 but a negative effect on
reflexive saccade latencies.23,24 In contrast, the effects of subthalamic nucleus (STN)
deep brain stimulation (DBS) on turning are more robust and in line with evidence
showing that DBS improves gait velocity and stride length in PD.25,26 The effects of DBS
on saccade function are also well documented. Rivaud-Pechoux et al.27 found a positive
effect of STN DBS on saccade gain during a memory guided saccade task. Sauleau et
al.28 also reported improvements with STN DBS in gain and latency of both saccades and
gaze during head fixed and head free reflexive saccade tasks, respectively. Finally, Temel
et al.29,30 found a marked improvement in saccade latency distributions with STN-DBS,
whereas dopaminergic medication had a negative effect on saccade latency.
While the effects of anti-parkinson medication on turning and oculomotor
function have been reported separately, as well as the effects of DBS on the latter, no
studies have examined the effect of levodopa on both turning and oculomotor function in
PD, and only one study has tested the effects of DBS on turning in PD.31 Therefore, the
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purpose of this study was to determine to separate and combined effects of levodopa and
STN DBS on turning performance and related oculomotor performance in PD. Based on
evidence that DBS improves both gait and oculomotor performance in PD, we
hypothesized that turning performance (time to turn) would be improved with DBS,
including an increase in initial saccade amplitude and alterations in the timing of the first
saccade relative to turn onset. We also hypothesized that levodopa would improve
turning and related oculomotor function, but to a lesser extent than DBS, and that the
combination of the two therapies would have an additive effect on turning performance.
We based the latter hypothesis on a study by Ferrarin et al.26 who showed that levodopa
and DBS provided an additive benefit in terms of gait speed, stride length, and
intersegmental range of motion during gait.
METHODS
Participants
Eleven individuals with idiopathic PD participated in this investigation.
Participants were recruited from a database of patients from Washington University
School of Medicine’s (WUSM) Movement Disorders Center. All participants met the
following inclusion criteria: aged 30 years or older, bilateral STN DBS and a minimum
of 3 months post implantation surgery, currently taking levodopa medication, normal
central (except for PD in the PD group) and peripheral neurological function, able to
stand independently for at least 30 minutes and walk independently without an assistive
device, no history of vestibular disease and no evidence or history of dementia.
Exclusionary criteria included: any serious medical condition other than PD, use of
neuroleptic or other dopamine-blocking drug, use of drug that might affect balance such
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as benzodiazepines, evidence of abnormality on brain imaging (previously done for
clinical evaluations-not part of this research), history or evidence of other neurological
deficit, such as previous stroke or muscle disease, and history or evidence of orthopedic,
muscular, or psychological problem that may affect task performance during the study.
Idiopathic PD was based on a diagnosis of “definite PD” by a board certified neurologist,
as previously described by Racette et al. 32 based upon established criteria.33,34 All
participants gave written informed consent to perform experimental procedures approved
by the Human Research Protection Office at WUSM.
Experimental Procedures
All study procedures were performed in the Locomotor Control Laboratory at
WUSM, which each participant visited on two separate days. Participants were tested in
the “on” state of their anti-Parkinson' medication for the entirety of one of the visits and
were in the “off” state for the entirety of the other visit (i.e. after a 12-hour withdrawal of
all anti-Parkinson medications). The order of these visits was counterbalanced. Within
each visit, the experimental protocol was performed twice; once with DBS stimulators
turned on using clinical settings, and once with DBS stimulators turned off. Again, the
order of these conditions was counterbalanced within the testing day. Prior to
commencing each round of the experimental protocol, the Movement Disorder Society
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Motor Subscale III was
administered according to Goetz et al.35 by a trained rater. The MDS-UPDRS-III is a
measure of severity of PD motor symptoms, as well as physical disability, and includes
measures of rigidity, gait, tremor, hand/arm and leg movements (bradykinesia), speech,
and facial expressions. The modified Hoehn and Yahr scale also was used to evaluate
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disease severity in PD36 and the FOG questionnaire (FOG-Q) was assessed to categorize
freezers and non-freezers.37
Saccade Task
To evaluate simple voluntary saccade function during an eyes only task,
participants performed saccades to targets positioned 20° to the left and right of a center
target. The task was performed in a seated position with the participant’s head positioned
in a chin-rest to minimize head movement and rotation, and the square targets (2.5 cm X
2.5 cm) were located at eye level on a white wall in front of the subject. Upon hearing an
auditory tone, subjects were instructed to react as quickly as possible by performing a
saccade to one of the lateral targets. Within each block of trials, the order of left and
right movements was randomized. Five trials were performed for each target.
Turning Protocol
Following the seated saccade task, participants completed in-place turns of 180°
amplitude. Instructions were given to perform the turns in a comfortable and normal
fashion. No specific auditory or visual cues were provided to cue turn onset or
completion other than directing subjects to “turn 180 degrees to face the wall behind
you.” Participants were instructed to begin the movement anytime after receiving the
turn direction instruction of left or right for the given trial. Turns were completed to both
the right and left in randomized order. Participants completed a minimum of 5 turns in
each direction. Data quality was visually monitored in real time and additional turns
were completed as needed to ensure an adequate number of quality trials for analysis.
Full body kinematic data were captured using an eight camera, passive marker, 3dimensional, high–resolution motion capture system (Motion Analysis Corporation,
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Santa Rosa, CA) sampling at 100 Hz in Cortex software (Motion Analysis Corporation,
Santa Rosa, CA). Thirty-four retro-reflective markers were positioned on the head (top
of head, back of head, left ear, right ear), trunk (left and right acromion, right scapula,
sternal notch, xyphoid process, 7th cervical vertebra, 12th thoracic vertebra), pelvis (left
and right anterior superior iliac spine, left and right posterior superior iliac spine,
sacrum), both legs (greater trochanter, anterior thigh, lateral femoral condyle, tibial
tuberosity, front of shank, lateral malleolus) and both feet (calcaneus, navicular, distal 2nd
metatarsal). Ocuolmotor data were captured using a head-mounted infrared binocular eye
tracking system (Applied Sciences Laboratory, Bedford, MA) and electrooculography
(EOG). Oculomotor data were captured synchronously at 1000Hz on the same PC
workstation with kinematic data in Cortex software.
Walking Task
To confirm the clinical benefit of both the medication and DBS stimulation,
subjects performed 3 trials of forward walking at a comfortable, self selected pace across
a 5 m instrumented, computerized GAITRite walkway (CIR Systems, Inc., Havertown,
PA). Gait velocity and stride length were used as measures of gait function.
Data Processing
Individual kinematic marker data and analog data were filtered using 4th order
low-pass Butterworth filters. Marker data were filtered in Cortex with a cut-off
frequency of 6 Hz while analog data were filtered in MotionMonitor (Innsport, Chicago,
IL) with a cut-off frequency of 20 Hz. Global and segment coordinate systems were
defined in MotionMonitor with the positive X-axis pointing anteriorly, positive Y-axis
pointing to the left, and positive Z-axis pointing upward vertically. For the turning task,
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rotations of the head, trunk, pelvis, and feet about global Z were extracted using a Z-X-Y
Euler sequence. Subsequently, kinematic angle data and filtered analog data were
exported for further processing in custom written MATLAB software (The Mathworks,
Inc., Natick, MA).
For the turning task, we characterized the timing of the rotation sequence by
identifying the time of onset of each segment yaw rotation (relative to the global
coordinate system). This was determined by identifying the first frame at which the yaw
rotation reached five degrees above baseline. Similar criteria were used to identify turn
offset, defined as the frame at which the yaw rotation came within five degrees of
maximal, final position. Eye tracker and EOG data were used to identify and measure
saccades occurring just prior to and during turn performance. Saccades were identified
visually and later confirmed to be true saccades if the maximum velocity of the eye
movement exceeded 30 degrees/sec.38,39 Onsets and offsets of the first saccade associated
with each turn were identified visually. Using these time points, saccade amplitude, peak
velocity, and timing of the first saccade relative to head and foot rotations were
calculated. Our primary variables of interest for the turning task were the amplitude and
velocity of the saccade initiating the turn, the total number of saccades performed during
the turn, turn duration, and the timing of the first saccade relative to the onset of the first
step. Secondary variables of interest included the timing of the turning sequence, i.e. the
timing of each body segment (head, trunk, pelvis) relative to the first step of the turn.
For the seated task, the first saccade following the auditory cue was measured in a
similar manner. Variables of interest were the latency of saccade onset with respect to
the auditory cue and saccade amplitude.
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Individual trials were excluded from analysis if eye position or body segment
rotations about the global Z-axis (during the turn task) were not static for at least 1000ms
prior to turn onset. Trials were also excluded if artifacts in oculomotor data due to blinks,
prolonged closure of eyelids, or other factors precluded measurement of the initial
saccade. Remaining trials were averaged to obtain a single data point for each
combination of medication and DBS state within each subject. For the turning and seated
tasks, left and right trials were combined for analysis as performance did not differ
between leftward and rightward trials.
Data Analysis
A two-way repeated measures ANOVA was used to evaluate the main effects of
medication status and DBS status as well as the interaction between the two for all
variables of interest. The criterion for statistical significance was set at p<0.05.
RESULTS
Demographic data are displayed in Table 1; performance data are displayed in
Tables 2 and 3. The main effect of DBS on MDS-UPDRS III scores was significant
(F=23.4, p=0.001), with DBS improving MDS-UPDRS III scores. Neither the main effect
of medication status (F=0.199, p=.665) nor the interaction (F=1.252, p=0.289) were
significant. DBS had a main effect on gait velocity (F=5.44, p=0.042) and stride length
(F=4.89, p=0.51), as both improved with DBS turned on. The main effect of medication
on gait velocity and stride length (F=0.047, p=0.83, F=0.248, p=0.629, respectively), as
well as the interaction between medication and DBS for the same two gait variables
(F=0.006, p=0.94, F=0.085, p=0.78, respectively), were not significant.
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Both DBS and medication improved turn duration as the main effects of both
were significant (F=7.77, p=0.019; F=5.08, p=0.048, respectively) while the interaction
was not (F=4.073, p=0.071). Similarly, DBS and medication each lowered the number of
saccades performed during turns (main effects: F=24.932, p=0.001; F=12.71, p=0.005,
respectively) and the interaction of DBS and medication was significant for number of
saccades (interaction F=7.70, p=0.02). For the amplitude of the first saccade performed
during the turn, the main effect of DBS was significant (F=36.515, p<0.001) as DBS
increased first saccade amplitude, while the main effect of medication (F=0.823,
p=0.386) and the interaction (F=0.725, p=0.414) were not. The main effect of DBS on
saccade velocity was significant (F=9.803, p=0.011) as DBS increased saccade velocity,
while the main effect of medication (F=1.551, p=0.241) and the interaction (F=0.593,
p=0.459) were not.
In characterizing the timing of the rotation sequence, there was a main effect of
DBS for the eye-head (F=6.416, p=0.03), eye-foot (F=10.435, p=0.009), and head-trunk
(F=6.382, p=0.030) latencies as DBS decreased the latencies between segment rotations.
Neither the main effects of medication nor the interactions were significant. When
dividing the latencies by the duration of the first gait cycle to obtain normalized latencies
in order to control for turning speed, each of the above main effects of DBS were
removed except for the normalized head-trunk latency (F=12.039, p=0.006). Finally,
during the seated tasks, there were no significant effects of DBS (F=1.224, p=0.297;
F=1.653, p=.231) or medication (F=0.294, p=0.601; F=0.803, p=0.394) in regards to
saccade latency or amplitude, respectively.
DISCUSSION
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The purpose of this study was to determine the independent and combined effects
of levodopa and DBS on measures of turning performance and related oculomotor
performance in PD. In summary, both DBS and levodopa had a profound effect on
turning duration as well as the number of saccades performed during the turn. DBS also
improved MDS-UPDRS III scores and gait parameters (velocity and stride length), while
levodopa did not. Secondly, the amplitude and velocity of the first saccade performed
during the turn was increased significantly by DBS but was not improved with levodopa.
Finally, the inter-segmental latencies between the eyes, head, trunk, and feet were
decreased by DBS but not by levodopa, however this effect was largely eliminated when
we controlled for turning speed.
To the best of our knowledge, this is the first study to address the therapeutic
effects of DBS on turning in PD as well as the first to measure the effects of DBS on
oculomotor function during a functionally relevant task. Our findings are consistent with
previous research that shows an improvement in motor symptoms, particularly gait, with
DBS. DBS was effective in increasing gait velocity by approximately 13% and stride
length by approximately 10% in our study. Our findings of improved turning duration
and concomitant improvements in oculomotor performance during turns are novel yet
anticipated based on the efficacy of DBS in improving saccade function and gait in
previous studies. Previous work in our lab (Lohnes and Earhart, 2011) showed that
persons with PD turn slower and with more steps than healthy, age-matched controls, and
that turn performance is correlated with oculomotor function such that individuals who
perform later, larger, faster, and fewer saccades turn better. Similarly, data herein
suggest that improved oculomotor performance associated with DBS is correlated with
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improved turn performance. Neither of these studies, however, address a cause-andeffect relationship between oculomotor and turn performance. Since the oculomotor
system initiates the turning sequence, we hypothesize that saccades occurring before and
early in the turn sequence may affect subsequent turning kinematics, but it is also
plausible that improvements in oculomotor function (as measured herein) are driven by
improved turn performance. For example, a decrease in the number of saccades
performed during the turn may be an effect of shortened turn duration and increased turn
speed. This is evidenced by the data in that the number of saccades performed per second
was greater with DBS ON compared with DBS OFF (2.34 saccades/sec vs. 1.94
saccades/sec, respectively). Thus, if our subjects had turned for the same length of time
with DBS both OFF and ON, they would have performed more saccades in the same
timeframe with DBS ON. Beyond the role of the oculomotor system, other factors are
also likely to contribute to the improved turn performance noted with DBS. DBS
improved overall MDS-UPDRS-III scores as well as bradykinesia, rigidity, and PIGD,
measures that are all independent from saccade function but could affect turn
performance. DBS also produced a shortening of intersegmental latencies (eye-head,
eye-foot, head-trunk). Again, while DBS-related improvements in saccade function could
have contributed to this, the decreased intersegmental latencies are most likely due to the
increased speed with which subjects were able to complete the turns during DBS
stimulation, hence shortening all aspects of the turn sequence. This hypothesis is
supported by the fact that intersegmental latencies were similar when we controlled for
the duration of the first gait cycle.
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Levodopa was not nearly as effective as DBS in improving gait and turning.
Turning duration and the number of saccades performed during the turns were improved
with medication, albeit to a lesser extent than with DBS, while gait velocity and stride
length, saccade amplitude and velocity, and turn sequence variables were unaffected by
levodopa. Subjects in this study did display a top-down rotation sequence in regards to
the timing of rotation onset of the various segments (eye-head, head-trunk, trunk-foot),
but it is possible that the turning sequence used herein is still more “en bloc” than the
pattern utilized by healthy controls. The presence of a top-down rotation sequence in the
current study is in contrast to Hong & Earhart8,19 which reported en bloc timing in a
group of non-DBS PD patients, and are in line with Anastasopoulos et al.13 who observed
a top-down rotation sequence in a sample of mild PD patients. On the other hand, our
study was similar to Hong & Earhart19 in that these timing characteristics did not change
when levodopa was taken. Conclusions related to the effects of levodopa in the present
study must be interpreted cautiously as these may be explained by a dosing issue, as
MDS-UPDRS III scores also did not improve with levodopa. Although we used
clinically prescribed doses of levodopa, these doses are most likely much less than the
maximally effective dose, as is often the case with DBS patients. Following DBS
implantation and resulting motor improvement, levodopa doses are often reduced
significantly to limit dyskinesias. As a result, the failure of levodopa to improve many of
the oculomotor and turning measures herein may be due to the limited doses used.
While DBS improved walking and turning performance, it did not improve
saccade performance during the seated saccade task, which is contrary to previous
research showing beneficial effects of DBS on saccade performance. There were,
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however, some methodological differences between ours and previous studies. Previous
studies examined the effects of DBS on both voluntary (memory guided saccades, antisaccades) and reflexive saccades using protocols where the saccade was cued visually
(either the appearance of a lateral target or the disappearance of the central target). In our
study, we used an auditory cue to initiate the saccade. Furthermore, our targets were
static in that they remained in view for the duration of the test. In contrast to memoryguided or anti-saccade paradigms where the subjects perform saccades to a target-less
location, our subjects made saccades toward a static visual target which may have served
as an external cue that facilitated performance.
Limitations
There are a few limitations related to this study. First, the use of clinical levodopa
doses was intended to increase the external validity of our study, but it is possible that in
doing so we missed potential therapeutic effects that would otherwise have been seen
with a maximally effective dose. As such, the reported effects of medication on turn and
oculomotor performance should be taken with caution and should not be extrapolated
beyond persons with PD and STN-DBS. It is likely that levodopa dosing is higher in
persons with PD but without DBS, and thus levodopa may have a more profound effect
on turning and related oculomotor performance than reported herein. It is also possible
that the effect of medication on persons with DBS differs from the effect of medication
on those without DBS. Further, we used a 12 hour levodopa withdrawal period before
OFF medication testing and a 45 minute rest period between DBS stimulator changes and
data collection. A 12 hour medication withdrawal period may have only resulted in a
partial off-medication state but due to the study design, a longer withdrawal period was
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not practical as full washout can take multiple days. In regards to DBS, it has also been
shown that 90% of changes in motor performance (UPDRS-III scores) occur within 45
minutes of DBS being turned off, and changes after DBS is turned on occur more
quickly, with 90% of changes in motor performance occurring in 15-20 minutes.41 While
our washout periods may not have resulted in full OFF or ON states, we feel the resulting
medication and DBS conditions are representative of clinical conditions. Another
limitation of this study is that we did not consider specific electrode placement within the
STN when selecting participants, resulting in some likely heterogeneity among subjects
in regards to stimulation localization within the STN. While saccade-related neurons are
clustered in the ventral STN,41,42 PD motor symptoms such as gait and balance appear to
respond similarly to dorsal and ventral STN DBS.43 As such, functional tasks that
significantly involve the oculomotor system (e.g. turning) may be best ameliorated by
DBS in the ventral STN. Selecting sub-groups of patients based on electrode placement
(i.e., dorsal vs. ventral STN) may offer further understanding of the effect of STN DBS
on oculomotor function during turning, but cognitive function must be considered in such
studies as response inhibition has been shown to decrease with ventral STN DBS.44
Finally, during the seated saccade task, we used a novel paradigm with static targets and
an auditory cue. This may explain the lack of effect of both DBS and medication on
saccade amplitude and latency.
Conclusions/Implications
In conclusion, STN DBS is largely effective in improving both straight walking
and turning performance in PD, including increases in saccade amplitude and a decreased
number of saccades required to complete the turn. These results add to the growing
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number of known benefits offered by DBS, and add to the functional applicability of
previous research that has found beneficial effects of DBS on saccades and gaze during
seated tasks. Future work may aim to define optimal DBS electrode placement for
patients whose primary motor complications include freezing during turning, or a history
of falls during turns.
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Figure 6. Representative data from individual turn trials showing eye-in-head, head-overground, and foot-over-ground rotations about the z (vertical) axis. Left column = DBS
OFF; Right column = DBS ON; Top row = Meds OFF; Bottom row = Meds ON. All
turns are to the right and are initiated with the right foot. Both DBS and levodopa
improve turn duration and reduce the number of saccades required to complete the turn.
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Figure 7. Effects of DBS and levodopa on oculomotor performance during turns.
*Significant main effect of DBS (p<0.05); † Significant main effect of Medication
(p<0.05); ‡ Significant interaction between DBS and Medication (p<0.05)
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Table 1. Subject Demographics
Age (years)
Male/Female
Disease Duration (years)
Hoehn & Yahr Stage (OFF/OFF)
Freezing of Gait Score
# of Freezers *
Disease Severity
MDS-UPDRS III

66.6 ±7.1
8/3
15.6 ± 6.6
2.6 ± 0.6
5.8 ± 4.4
3

DBS OFF/
DBS ON/
Meds OFF
Meds OFF
45.81 ± 10.0 32.5 ± 8.8

DBS OFF/
Meds ON
43.0 ± 9.5

Values are means ± standard deviations.
* Reported freezing at least once/week on item 3 of the FOG-Q.
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DBS ON/
Meds ON
30.2 ± 6.0

Table 2. GAITRite and Seated Saccade Task Data
DBS OFF

DBS ON

Mean ± SD

100.8 ± 25.3
100.2 ± 20.1

*

106.8 ± 20.5
106.5 ± 16.5
106.6 ± 18.5

108.6 ± 21.6
110.0 ± 18.1

*

113.4 ± 17.9
115.7 ± 15.7
114.6 ± 16.8

335.0 ± 104.0
355.6 ± 95.5
345.3 ± 99.8

335.4 ± 101.0
345.5 ± 92.4

16.0 ± 1.3
16.3 ± 3.2
16.1 ± 2.2

15.49 ± 1.7
16.02 ± 5.7

GAITRite Data
Gait Velocity (cm/s)
Meds OFF
Meds ON
Mean ± SD

94.9 ± 30.1
93.9 ± 23.6
94.4 ± 26.9

Stride Length (cm)
Meds OFF
Meds ON
Mean ± SD

103.8 ± 25.2
104.2 ± 20.4
104.0 ± 22.8

Seated Saccade Task
Saccade Latency (ms)
Meds OFF
Meds ON
Mean ± SD

335.8 ± 98.0
335.3 ± 89.3
335.5 ± 93.7

Saccade Amplitude (°)
Meds OFF
15.0 ± 2.1
Meds ON
15.8 ± 2.5
Mean ± SD
15.4 ± 2.3
Values are means ± standard deviations.
* Significant main effect of DBS (p<0.05)
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Table 3. Kinematic Performance Data
DBS OFF

DBS ON

Mean

Eye-Head Latency (ms)
Meds OFF
Meds ON
Mean ± SD

320.3 ± 275.6
261.2 ± 143.5
290.8 ± 209.6

244.6 ± 204.6
206.6 ± 123.2

*

168.9 ± 133.6
151.9 ± 102.8
160.4 ± 118.2

Head-Trunk Latency (ms)
Meds OFF
Meds ON
Mean ± SD

71.5 ± 115.1
55.7 ± 62.6
63.6 ± 88.8

41.7 ± 81.6
41.6 ± 62.6

*

11.8 ± 48.2
27.4 ± 62.7
19.6 ± 55.5

Eye-Foot Latency (ms)
Meds OFF
Meds ON
Mean ± SD

667.2 ± 438.1
569.2 ± 527.3
618.2 ± 482.7

500.9 ± 364.0
409.0 ± 350.8

*

334.5 ± 289.8
248.7 ± 174.3
291.6 ± 232.1

N. Eye-Head Latency (% First Gait cycle)
Meds OFF
306.8 ± 179.4
Meds ON
269.0 ± 96.4
Mean ± SD
287.9 ± 137.7

247.4 ± 277.4
190.2 ± 92.2
218.8 ± 184.6

277.1 ± 228.4
229.6 ± 94.3

N. Eye-Foot Latency (% First Gait cycle)
Meds OFF
48.8 ± 33.5
Meds ON
59.0 ± 47.0
Mean ± SD
54.4 ± 40.3

59.9 ± 76.7
33.2 ± 24.8
46.51 ± 50.8

54.3 ± 55.1
46.1 ± 35.9

N. Head-Trunk Latency (% First Gait cycle)
Meds OFF
7.5 ± 12.1
Meds ON
7.3 ± 8.0
Mean ± SD
7.4 ± 10.0
N. Head-Foot Latency (% First Gait cycle)
Meds OFF
18.2 ± 29.2
Meds ON
30.5 ± 40.4
Mean ± SD
16.9 ± 35.0
Values are means ± standard deviations.
* Significant main effect of DBS (p<0.05)

*

2.7 ± 6.6
3.6 ± 6.0
3.2 ± 6.3

35.1 ± 49.9
15.7 ± 22.3
22.3 ± 33.0
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5.1 ± 9.3
5.5 ± 7.0

26.6 ± 39.6
23.1 ± 31.4
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Chapter 5: Conclusion
Summary of Findings
Previous research has shown that individuals with PD suffer from bradykinesia
that affects both the limbs and eyes. Further, these patients also have difficulty switching
between motor patterns which results in functional impairments such as turning difficulty
and freezing of gait. Previous work also demonstrated direction switching impairments
in the upper extremity and during postural control tasks, but not yet in the eyes and lower
limb. In Chapter 2, we noted that the ability of individuals with PD to switch between
movement orientations is in fact decreased during lower limb and oculomotor tasks, but
that bradykinesia appears to be the underlying cause of this impairment. Further, switch
times correlated between eyes and lower limb, suggesting parallel declines in switching
ability in the eyes and lower limb.
It is well known that the turning difficulty experienced by persons with PD is
characterized by a more “en bloc” turning sequence. However, it was previously unclear
how eye movement function contributed to this impairment. In Chapter 3, we provided
the first evidence that saccadic eye function is impaired in PD during turning and that the
amount of oculomotor dysfunction is correlated with turn performance.
Improving turning in patients with PD may reduce the incidence of falls and
injuries, yet the effect of interventions on turning is not understood. As levodopa has the
potential to improve saccades and DBS is widely accepted to do so, it was hypothesized
in chapter 4 that such interventions may improve turning as well since turns are initiated
with a saccade. Indeed, our findings show that levodopa improves turning duration, but
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not related oculomotor function, while DBS has a strong influence on turning
performance and the related oculomotor strategy.
Significance and Clinical Implications
Taken together, these studies corroborate previous research that voluntary saccade
function is impaired in PD, and expand on these finding by delineating how dysfunctional
saccades affect a functional task (turning). Studying the oculomotor system and related
dysfunction in PD has offered us a better understanding of basal ganglia function and
dysfunction. As the oculomotor system is simple and largely understood, it is well suited
for studying behavior in a controlled and systematic manner, free from many confounders
often involved in the study of more complex motor symptoms. However, many
conclusions drawn from oculomotor research lack apparent or immediate therapeutic
relevance and may not have implications that will improve function and quality of life in
persons with PD. In contrast, our findings bridge the gap between oculomotor
impairments and systemic motor function and may have implications for clinical care.
One of the main implications of this research is that oculomotor dysfunction in
PD correlates well with turning performance. While identifying a cause and effect
relationship was beyond the scope of this work, our shown association between saccades
and turning provides rationale for targeting the oculomotor system with therapeutic
interventions and rehabilitation. For example, it is well known that both internally and
externally generated cues can improve motor function in PD. Visual cues, such as lines
on the floor, increase stride length and velocity during gait, and auditory cues have shown
similar benefits.1-5 Cues are also efficacious in ceasing episodes of freezing.6 In light of
this, and since saccade function is largely maintained in the presence of visual triggering,
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the possibility of cueing the oculomotor system to improve turning performance is
apparent. Since individuals with PD initiate the turn sequence with a smaller saccade
than age-matched controls, a potential cueing strategy could include a large saccade to a
lateral target before initiating the turn sequence. This may elicit a more-top down rotation
sequence.
A second implication of this research relates to the importance of understanding
how medications and DBS affect the whole spectrum of functional impairments in PD.
This work adds to this understanding by providing insights into the effects of these two
interventions on turning. While symptoms such as tremor, forward gait, and non-motor
complications may dominate for some patients, FOG and TD may be chief complaints of
others. The ability to tailor interventions on a patient-by-patient basis is paramount, but
science is still working toward a full understanding of how each intervention affects PD,
both positively and negatively. Our results add rationale for STN DBS as therapy for
patients whose symptoms include TD. Further, our results suggest a potential mechanism
for the observed improvements in turning through facilitation of saccades.
Limitations
One limitation of this work is that it is correlative in nature. While we have
shown that saccade function relates to turning performance and that DBS improves both,
our results do not tell us if oculomotor control independently controls turning
performance nor whether improving oculomotor control improves turning independent of
other factors. Secondly, turning in these studies was limited to in-place turns as opposed
to turns during gait. It is possible that differences exist between in-placing turning and
turning in the midst of walking. Finally, all observations were performed in a laboratory
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environment and participants were aware they were being monitored. It is possible that
motor strategies used outside the laboratory may differ from those measured within the
laboratory.
Suggestions for Future Research
The influence of the oculomotor system on functional tasks is still poorly
understood. While we demonstrate herein that saccade function is correlated with turn
performance, we do not provide sufficient evidence to support causality. Therefore,
future studies should aim to answer whether saccades that occur during turning do in fact
affect turn performance. This may be achieved by manipulating the parameters of the
initial saccade such as the amplitude or timing relative to turn onset. Further, locomotor
tasks such as obstacle navigation, crossing barriers, and walking through narrow passages
often invoke freezing in persons with PD. It is possible that the oculomotor strategy used
during these situations differs in PD, perhaps by focusing attention on a different part of
the environment or using a temporal scanning sequence that differs from controls. If
such were the case, it would again be interesting to modify subjects’ oculomotor strategy
and measure subsequent changes in task performance.
Secondly, the effect of rehabilitative interventions, such as visual cueing, on
turning has not yet been addressed. Since cueing has shown great promise in improving
locomotion in PD, a study of the effects of oculomotor cueing on turning is warranted.
This could include both externally generated visual cues as well as internally generated
cues such as thinking about making a larger saccade prior to turning.
Finally, since neurons related to oculomotor function are largely sequestered in
the ventral region of the STN, research into the differential effects of dorsal vs. ventral
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stimulation of the STN on oculomotor performance and subsequent turning performance
would be beneficial. Such data could provide additional rationale for specific electrode
placement within the STN.
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